Particularly, our findings highlight the association between Reelin and these AD-associated but not exclusive markers in at least ERM tissues, suggesting new alternative diagnostic tools not restricted to the visual system and potential therapeutic targets for counteracting neurodegeneration. The gene discussed is RELN; the disease is Alzheimer disease.